Targeting Mitochondrial Oncometabolites: A New Approach to Overcome Drug Resistance in Cancer
Drug resistance is the main obstacle for a successful cancer therapy. There are many mechanisms by which cancers avoid drug-mediated death, including alterations in cellular metabolism and apoptotic programs. Mitochondria represent the cell’s powerhouse and the connection between carbohydrate, lipid...
Main Authors: | Martina Godel, Giacomo Ortone, Dario Pasquale Anobile, Martina Pasino, Giulio Randazzo, Chiara Riganti, Joanna Kopecka |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/5/762 |
Similar Items
-
The emerging role of fumarate as an oncometabolite
by: Ming eYang, et al.
Published: (2012-07-01) -
Metabolic Alterations in Cancer Cells and the Emerging Role of Oncometabolites as Drivers of Neoplastic Change
by: Zhengqiu Zhou, et al.
Published: (2018-01-01) -
Oncometabolites as biomarkers in thyroid cancer: a systematic review
by: Khatami F, et al.
Published: (2019-02-01) -
From Metabolism to Genetics and Vice Versa: The Rising Role of Oncometabolites in Cancer Development and Therapy
by: Emanuela Di Gregorio, et al.
Published: (2021-05-01) -
Oncometabolites and the response to radiotherapy
by: Kexu Xiang, et al.
Published: (2020-08-01)